Sanofi Consumer Healthcare India Limited (NSE:SANOFICONR)

NSE:SANOFICONR Balance Sheet

Financials in millions INR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023
Cash & Equivalents	-	3,269	16
Cash & Short-Term Investments	2,169	3,269	16
Cash Growth	82.73%	20331.25%	-
Accounts Receivable	-	137	316
Other Receivables	-	38	2,048
Receivables	-	181	2,369
Inventory	-	409	966
Prepaid Expenses	-	20	-
Other Current Assets	-	38	1
Total Current Assets	-	3,917	3,352
Property, Plant & Equipment	-	279	20
Other Intangible Assets	-	19	55
Long-Term Deferred Tax Assets	-	62	19
Other Long-Term Assets	-	36	8
Total Assets	-	4,313	3,454
Accounts Payable	-	703	600
Accrued Expenses	-	283	129
Current Portion of Leases	-	37	-
Current Income Taxes Payable	-	3	521
Other Current Liabilities	-	280	49
Total Current Liabilities	-	1,306	1,299
Long-Term Leases	-	166	-
Pension & Post-Retirement Benefits	-	111	79
Total Liabilities	-	1,583	1,378
Common Stock	-	230	20
Retained Earnings	-	2,293	1,649
Comprehensive Income & Other	-	207	407
Shareholders' Equity	2,570	2,730	2,076
Total Liabilities & Equity	-	4,313	3,454
Total Debt	283	203	-
Net Cash (Debt)	1,886	3,066	16
Net Cash Growth	91.47%	19062.50%	-
Net Cash Per Share	81.89	133.13	0.69
Filing Date Shares Outstanding	23.03	23.03	2
Total Common Shares Outstanding	23.03	23.03	2
Working Capital	-	2,611	2,053
Book Value Per Share	111.61	118.54	1038.00
Tangible Book Value	2,557	2,711	2,021
Tangible Book Value Per Share	111.04	117.71	1010.50
Machinery	-	81	45
Construction In Progress	-	7	-
Leasehold Improvements	-	53	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.